Drugs for malaria: What is in the pipeline? Few new products in the fight against malaria;Wenig neues im kampf gegen die malaria: Wirkstoffe gegen malaria: Was ist in der pipeline?

Pharmazie in Unserer Zeit

Volumn 38, Issue 6, 2009, Pages 522-526

  Schlitzer, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; AZITHROMYCIN; CHLOROQUINE; DIPYRONE; EUARTESIM; FOSMIDOMYCIN; MEFLOQUINE; PYRAMAX; PYRONARIDINE; TAFENOQUINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

CLINICAL TRIAL; DRUG STRUCTURE; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; REVIEW; ANIMAL; DRUG DEVELOPMENT; DRUG EFFECT; DRUG RESISTANCE; PLASMODIUM; PSYCHOLOGICAL ASPECT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMALARIALS; DRUG DISCOVERY; DRUG RESISTANCE; HUMANS; MALARIA; PLASMODIUM;

EID: 70450280714     PISSN: 00483664     EISSN: 16151003     Source Type: Journal    
DOI: 10.1002/pauz.200900339     Document Type: Review

References (10)

1. http//:www.mmv.org
2. Schlitzer, M.: Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development. ChemMedChem 2 (2007), 944-986.
3. Schlitzer, M.: Antimalarial drugs - what is in use and what is in the pipeline. Arch. Pharm. Chem. Life Sci. 341 (2008), 149-163.
4. Davis, T.M., Hung, T.Y., Sim, I.K., Karunajeewa, H.A., Ilett, K.F.: Piperaquine: a resurgent antimalarial drug. Drugs 65 (2005), 75-87.
5. Ramharter, M., Kurth, F., Schreier, A.C., Nemeth, J., von Glasenapp, I., Bélard, S., Schlie, M., Kammer, J., Koumba Koumba, P., Cisse, B., Mordmüller, B., Lell, B., Issifou, S., Oeuvray, C., Fleckenstein, L., Kremsner, P.G.: Fixed-Dose Pyronaridine- Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon. J. Infect. Dis. 198 (2008), 911-919.
6. [Noedl, H., Krudsood, S., Chalermratana, K., Silachamroon, U., Leowattana, W., Tangpukdee, N., et al.: Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin. Infect. Dis. 43 (2006), 1264-1271.
7. Wiesner, J., Reichenberg, A., Heinrich, S., Schlitzer, M., Jomaa, H.: The plastid-like organelle of apicomplexan parasites as drug target. Curr. Pharm. Des. 14 (2008), 855-871.
8. Dubar, F., Khalife, J., Brocard, J., Dive, D., Bioth, C.: Ferroquine, an ingenious antimalarial drug. Thoughts on the mechanism of action. Molecules 13 (2008), 2900-2907.
9. Coslédan, F., Fraisse, L., Pellet, A., Guillou, F., Mordmüller, B., Kremsner, P.G., Moreno, A., Mazier, D., Maffrand, J-P., Meunier, B.: Selection of a trioxaquine as an antimalarial drug candidate. Proc. Natl. Acad. Sci. USA 105 (2008), 17579-17584.
10. Le Roche, K., Johnson, J., Ahiboh, H., Chung, W., Prudhomme, J., Plouffe, D., Henson, K., Zhou, Y., Witola, W., Yates, J., Mamoun C., Winzeler, E., Vial, H.: A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparum. BMC Genomics 9 (2008), 513.